5502
E. Hasegawa et al. / Tetrahedron 71 (2015) 5494e5505
cleavage, which initiates Dowd-Beckwith ring-expansion and 5-exo
hexenyl cyclization processes and allylation reactions of acyl for-
mates. On the other hand, hydroxynaphthyl substituted DMBIH,
which acts as a formal two-electron and two-proton-donor, is ef-
fective in promoting transformations of epoxy ketones to aldols and
deproptection reactions of N-sulphonyl indoles. Notably, we dem-
onstrated that the imidazolium salt product can be recovered after
the reaction and transformed to the starting Ar-DMBIH by hydride
reduction. Unfortunately, the species generated by the photoexci-
tation of Ar-DMBIH and that responsible for the initial single
electron reduction of the substrates could not be identified by using
time resolved laser spectroscopy. However, it is believed that in the
case of the pyene substituted DMBIH, photoexcitation of aryl
chromophore followed by intramolecular SET generates a zwitter-
ionic biradical that could serve as the electron donor in the PET
process. Since some of Ar-DMBIH designed and prepared in this
study have absorption spectra that extend into the visible region,
their application in visible light promoted transformations are
possible. We are pursuing this proposal in our current
investigations.
was stirred for 6 h in an ice-water bath and then molecular sieves
were removed by filtration. The residue obtained after concentra-
tion of the filtrate in vacuo was subjected to column chromatog-
raphy (benzene with 1% triethylamine) to give 1b (1.85 g, 6.8 mmol,
67%). In a similar fashion, 1c (1.61 g, 5.9 mmol, 71%) from DMPDA
(1.12 g, 8.2 mmol) and 1e (1.30 g, 4.0 mmol, 50%) from DMPDA
(1.09 g, 8.0 mmol) were prepared. 1d (1.74 g, 5.0 mmol, 61%) from
DMPDA (1.12 g, 8.2 mmol) was rinsed with MeOH after column
separation. While 1b, 1c, and 1e were crystallized from dime-
thoxyethane and EtOH, 1d was crystallized from CH2Cl2 and MeOH
before using for the photoreactions. 1f (595 mg, 2.1 mmol, 49%)
from DMPDA (584 mg, 4.3 mmol) was obtained by rinsing the solid
with EtOH after column chromatography (EtOAc/benzene¼1/6
with 1% triethylamine), and then used for the photoreaction.
4.2.1. 1,3-Dimethyl-2-(1-naphthyl)benzimidazoline (1b). Pale yel-
low solid; mp 123.5e124.0 ꢃC; 1H NMR (400 MHz, CDCl3)
d 8.67 (br
s, 1H), 7.89 (t, J¼8.6 Hz, 2H), 7.59 (br s, 1H), 7.49e7.39 (m, 3H),
6.79e6.75 (m, 2H), 6.51e6.47 (m, 2H), 5.41 (br s, 1H), 2.55 (s, 6H);
13C NMR (100 MHz, CDCl3)
d 142.1, 134.4, 133.3, 132.2, 130.3, 129.0,
128.5, 125.7, 124.7, 119.2, 105.8, 33.3; HRMS (ESI) m/z calcd for
4. Experimental section
4.1. General
C
19H17N2 [MꢀH]þ 273.1386, found 273.1378.
4.2.2. 1,3-Dimethyl-2-(2-naphthyl)benzimidazoline (1c). Pale yel-
low solid; mp 124.5e126.0 ꢃC; 1H NMR (400 MHz, CDCl3)
NMR spectra were recorded using CDCl3 or DMSO-d6 solutions
with tetramethylsilane (Me4Si) as an internal standard at 400 MHz
for 1H NMR and 100 MHz for 13C NMR. High-resolution mass
spectra (HRMS) were recorded on a double focusing mass spec-
trometer by using electrospray ionization (ESI). Uncorrected melt-
ing points are reported. Oxidation and reduction potentials in
MeCN were measured using cyclic voltammetry and the previously
described procedure.10h Calibration of the potential values were
performed using the formal potentials of ferrocene/ferrocenium
couple, Eꢃ¼0.069e0.072 V and 0.434e0.446 V versus Ag/AgNO3
and SCE, respectively. Photoreactions were conducted using solu-
tions in Pyrex test tubes (1.4 cm diameter) immersed in a water
bath at room temperature and irradiated using a 500 W Xe lamp.
Column chromatography was performed using silica gel. Pre-
parative thin-layer chromatography (TLC) was performed on
20ꢁ20 cm plates coated with silica gel. Anhydrous solvents for
photoreactions and preparations of some substrates were obtained
as follows. Tetrahydrofuran (THF) was distilled over sodium-
benzophenone under N2. CH2Cl2 and PhCH3 were purified in
a same manner by the treatment with H2SO4, water, 5% NaOH,
water, and CaCl2 and then distilled over CaH2. MeCN was distilled
over P2O5 and subsequently distilled with K2CO3. Anhydrous N,N-
dimethylformamide (DMF), dimethyl sulfoxide (DMSO), PhCF3, and
MeOH were purchased and used without distillation. Other re-
agents and solvents were purchased and used without purification.
Substrates 2ae2e,10c 4a,19f 4b,10j 4c,19f 4d,10l 4e,10l 8,10h 10,10c and
12a,23 12b,30 12c,31 12d,32 which are known compounds, were
prepared by using reported procedures. Compounds 14a and 14b
are commercially available.
d
7.92e7.82 (m, 5H), 7.55e7.51 (m, 2H), 6.77e6.72 (m, 2H),
6.49e6.45 (m, 2H), 5.06 (s, 1H), 2.59 (s, 6H); 13C NMR (100 MHz,
CDCl3) 142.1, 136.4, 134.2, 128.9, 128.6, 128.1, 127.9, 126.5, 126.3,
d
125.6, 119.4, 105.8, 94.3, 33.2; HRMS (ESI) m/z calcd for C19H17N2
[MꢀH]þ 273.1386, found 273.1383.
4.2.3. 1,3-Dimethyl-2-(1-pyrenyl)benzimidazoline
(1d). Yellow
8.86 (br s,
solid; mp 161.0e161.5 ꢃC; 1H NMR (400 MHz, CDCl3)
d
1H), 8.22e8.20 (m, 3H), 8.14e8.00 (m, 4H), 6.84e6.79 (m, 2H),
6.56e6.52 (m, 2H), 5.84 (br s, 1H), 2.60 (s, 6H); 13C NMR (100 MHz,
CDCl3)
d 142.1, 132.1, 130.8, 130.6, 128.3, 128.0, 127.3, 126.0, 125.4,
125.3, 124.7, 124.5, 119.4, 105.9, 33.4; HRMS (ESI) m/z calcd for
C
25H19N2 [MꢀH]þ 347.1543, found 347.1543.
4.2.4. 2-(9-Anthryl)-1,3-dimethylbenzimidazoline
(1e). Orange
9.13 (d,
solid; mp 177.0e178.0 ꢃC; 1H NMR (400 MHz, CDCl3)
d
J¼9.2 Hz, 1H), 8.56e8.54 (m, 2H), 8.07e8.00 (m, 2H), 7.55e7.45 (m,
3H), 7.39e7.35 (m, 1H), 6.85e6.81 (m, 2H), 6.65 (s, 1H), 6.57e6.53
(m, 2H), 2.53 (s, 6H); 13C NMR (100 MHz, CDCl3)
d 142.4, 132.1,
130.8, 130.0, 129.7, 128.7, 127.2, 126.7, 126.6, 125.2, 125.0, 124.6,
121.5, 119.6, 106.3, 87.8, 33.5; HRMS (ESI) m/z calcd for C23H19N2
[MꢀH]þ 323.1543, found 323.1533.
4.2.5. 1,3-Dimethyl-2-(2-hydroxy-1-naphthyl)benzimidazoline
(1f). Pale yellow solid; mp 123.5e124.0 ꢃC; 1H NMR (400 MHz,
CDCl3)
7.51e7.45 (m, 1H), 7.35 (t, J¼7.4 Hz, 1H), 7.20 (d, J¼9.2 Hz, 1H),
6.90e6.84 (m, 2H), 6.68e6.63 (m, 2H), 5.84 (s, 1H), 2.68 (s, 6H); 13
NMR (100 MHz, CDCl3) 157.6, 142.2, 134.5, 131.6, 129.2, 128.5,
d
10.43 (br s, 1H), 8.02 (d, J¼8.8 Hz, 1H), 7.85e7.80 (m, 2H),
C
d
127.0, 122.8, 121.0, 120.1, 109.0, 108.6, 87.8, 33.9; HRMS (ESI) m/z
4.2. Preparations of 2-aryl-1,3-dimethylbenziimidazoline
(DMBIH) (1)
calcd for C19H17N2O [MꢀH]þ 289.1335, found 289.1325.
4.3. Preparation of 1,2,3-trimethyl-2-
pyrenylbenziimidazoline (1d-Me)
DMBIH 1a,7a 1b,8b, and 1g,8c are known compounds. 1c, 1d, 1e,
and 1f were prepared by using modified literature procedur-
es.6a,8b,c,10g A typical procedure for preparation of 1b is described
below. To a CH2Cl2 (10 mL) containing N,N0-dimethyl-o-phenyl-
enediamine (DMPDA) (1.38 g, 10.1 mmol) with molecular sieves 4A
(ca. 10g) under N2 seated in ice-water bath was slowly added 1-
naphthoaldehyde (1.42 mL, 10.5 mmol) in CH2Cl2 (20 mL). After
addition of acetic acid (0.23 mL, 4.0 mmol), the resulting mixture
To a benzene solution (8 mL) containing N,N0-dimethyl-o-phe-
nylenediamine (400 mg, 2.9 mmol) with molecular sieves 4A (ca.
6.5g) was slowly added 1-acetylpyrene33 (2.13 g, 8.7 mmol) in
benzene (13 mL) under N2. After addition of trifluoroacetic acid
(0.23 mL, 3.0 mmol), the resulting mixture was stirred at reflux for
24 h and filtered. To the residue obtained after concentration of the